Skip to content
ppharmaranks
Menu
Class IIOngoing

Ketamine Hydrochloride Injectable Solution recall

FDA recall D-0507-2026 · initiated Apr 1, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated May 6, 2026How we research

Wells Pharma of Houston LLC recalled Ketamine Hydrochloride Injectable Solution in Apr 2026 — an FDA Class II recall (D-0507-2026) because cGMP deviations.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

cGMP deviations.

The manufacturing process itself

The FDA found the process itself out of compliance, usually before any defective product was identified.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

120925302312764, Exp Date 04/09/2026, 123125302312879 Exp Date, 05/05/2026, 123125302312880, Exp Date 05/05/2026, 010226302310003, Exp Date 05/06/2026, 010626302310007, Exp Date 05/08/2026, 010626302310008, Exp Date 05/08/2026 020426302310243, Exp Date 06/06/2026.

Quantity recalled: 4975 syringes

Details

Product
Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31.
Recalling company
Wells Pharma of Houston LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S. Nationwide.
Initiated
Apr 1, 2026
FDA report date
May 6, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Ketamine Hydrochloride Injectable Solution recalled?
Wells Pharma of Houston LLC recalled Ketamine Hydrochloride Injectable Solution in Apr 2026 — an FDA Class II recall (D-0507-2026) because cGMP deviations. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Ketamine Hydrochloride Injectable Solution recalled?
Per the FDA enforcement record, the reason for recall D-0507-2026 was: cGMP deviations.
Is a recalled Ketamine Hydrochloride Injectable Solution dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Ketamine Hydrochloride Injectable Solution are affected?
Distributed: U.S. Nationwide.. The recall covers these lots — 120925302312764, Exp Date 04/09/2026, 123125302312879 Exp Date, 05/05/2026, 123125302312880, Exp Date 05/05/2026, 010226302310003, Exp Date 05/06/2026, 010626302310007, Exp Date 05/08/2026, 010626302310008, Exp Date 05/08/2026 020426302310243, Exp Date 06/06/2026.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0507-2026.

Source: openFDA Drug Enforcement record D-0507-2026

← All drug recalls